Our Clients and Collaborators

scroll down

Fusion Antibodies has worked with many pharmaceutical companies, universities and government agencies around the globe.

Our world class, reliable, professional contract research services allow these companies to speed up their drug development processes, optimise their expression protocols and discover their antibody sequences.

Partnership with Celonic AG

Celonic Logo

Fusion Antibodies have entered into a partnership with Swiss contract manufacturing organisation Celonic AG to collaborate on the development of high yield stable cell lines. The deal will allow clients of Fusion Antibodies a direct & efficient supply path to clinical trial material by taking advantage of the scale-up and development capabilities of Celonic.

Celonic is a CDMO/CMO based in Basel, Switzerland offering clients the development and manufacturing services for New Biological Enities (NBEs) and Biosimilars worldwide. The services include the development of cell lines, production processes as well as the GMP and non-GMP manufacturing of biopharmaceutical drug substances. In addition Celonic licenses its proprietary SEFEX cell line technology to clients, drug developers and other service provider.

Visit Celonic's website at www.celonic.com.

C-Term Diagnostics

C-Term Diagnostics LogoFusion Antibodies have been collaborating with C-Term Diagnistics for over 5 years and have developed a bladder cancer ELISA kit for detection of the unphosphorylated and TFSTP-Pser258 isoforms of Tissue Factor Signal Transduction Peptide in unfractionated and fractionated urine samples. The detection assay is currently going through CE marking and substantial clinical trials in the UK coordinated by Fusion Antibodies. IVD kits are in development and lateral flow and other formats are in early stage development also. Trials already performed have established 90% sensitivity and specificity.
 
Of particular note is the tests capability of detecting early stage Bladder Cancer with great accuracy.

Visit C-Term's website at www.ctermdiagnostics.com.

BizCom Japan 

Bizcom Japan Logo

BizCom Japan, Inc. is a trading and consulting company based in Tokyo, Japan. From its foundation in 1996, it has been collaborating with various innovative companies in biotechnology, pharmaceutical, diagnostic, cosmetic and medical device industries. In addition to providing research reagents, services and equipment to the life science researchers, BizCom Japan gives personalized solutions to its clients.

BizCom Japan act as Fusion Antibodies distributor to the Japanese market.

More information is available at http://www.bizcomjapan.com/

Other Clients

University College Dublin Logo   Opsona Therapeutics Logo   Ribovax Biotech Logo   Arius Research Logo   Monash Institute of Medical Research Logo
Bio Uetikon Logo   Enfer Group Logo   Abcam Logo   Novus Biologicals Logo   Arana Therapeutics Logo
Alltech Logo   AFFiRiS Logo   BellBrook Labs Logo   Draper Laboratory Logo   Lostam Pharamaceuticals Logo
Aglaia Biomedical Ventures Logo   Coventry Diagnostics Logo   Lentigen Logo   Gentian Logo   Angelica Therapeutics Logo
Belfast Health and Social Care Trust Logo   Clavis Pharma Logo   Pain Therapeutics Logo   Orion Pharma Logo   Axis Shield Logo
University of Sheffield Logo   Gent University Logo   Imperial College London Logo   Inven2 Logo   Henry Jackson Foundation Logo
Argutus Medical Logo   Dako Logo   Manchester University Logo   Humanitas Logo   Stab Vida Logo

Make an Enquiry

Feel free to get in touch for any further information. We would love to hear from you.

Contact Us